Back |
home / stock / prta / prta message board
Subject | By | Source | When |
---|---|---|---|
Jake13: PRTA Year to date has changed -10.44% percent. +29.22% in the last 30 days. $PRTA Prothena C | Jake13 | investorshangout | 11/12/2014 2:52:27 PM |
chartguy89: PRTA 23.75 Prothena Corporation Plc Stock Charts $PRTA Last Updated: 11/11/14 Last price | chartguy89 | investorshangout | 11/12/2014 1:48:54 PM |
danrocks: Right now PRTA is number 101 for the largest percentage gain out of 250 stocks. $PRTA PRTA | danrocks | investorshangout | 11/11/2014 6:08:03 PM |
chartguy89: PRTA 23.48 Prothena Corporation Plc Stock Charts $PRTA Last Updated: 11/10/14 Last price | chartguy89 | investorshangout | 11/11/2014 2:26:45 PM |
Jake13: PRTA Year to date has changed -11.46% percent. +27.75% in the last 30 days. $PRTA Prothena C | Jake13 | investorshangout | 11/11/2014 1:26:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
Prothena Corporation plc Website:
2024-07-03 23:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-02 10:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will initiate a Phase 1 clinical trial for PRX019 in 2024 Prothena Corporation plc (NASDAQ:PRTA),...